GREBT Accelerates Entry into the Bulgarian Market with Its AI-Based Cardiovascular Disease Prediction Platform

GREBT, a bio-healthcare specialized company led by CEO Choi Hang-joo, announced on the 28th that it has signed a memorandum of understanding (MOU) with Bulgaria-based PanaxTech to expand into the Bulgarian market.

Through this agreement, GREBT plans to actively promote the export of its data platform and measurement devices designed for the prevention and management of cardiovascular diseases in Bulgaria.

PanaxTech is a primary vendor within Bulgaria’s large-scale distribution networks across the food and beverage, cosmetics, and consumer goods sectors. Under the agreement, PanaxTech will be responsible for local distribution and market development to support GREBT’s market entry.

This partnership is a result of the SW Convergence Cluster 2.0 Project, an initiative led by the Sejong Technopark to foster the regional digital content industry and strengthen the related industrial ecosystem.